[{"Assets_0_Q3_USD":47866000.0,"CommonStockSharesOutstanding_0_Q3_shares":15645545.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-9168000.0,"NetIncomeLoss_1_Q3_USD":-4887000.0,"NetIncomeLoss_3_Q3_USD":-12195000.0,"StockholdersEquity_0_Q3_USD":45823000.0,"Ticker":"BTAI","CIK":"1720893","name":"BIOXCEL THERAPEUTICS, INC.","OfficialName":"BioXcel Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"417746551.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181109"}]